We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Gsk Plc | LSE:GSK | London | Ordinary Share | GB00BN7SWP63 | ORD 31 1/4P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
-1.00 | -0.06% | 1,638.50 | 1,638.50 | 1,639.00 | 1,656.00 | 1,637.00 | 1,650.50 | 1,050,378 | 13:30:45 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Pharmaceutical Preparations | 30.33B | 4.93B | 1.1970 | 13.76 | 67.81B |
Date | Subject | Author | Discuss |
---|---|---|---|
15/8/2022 21:13 | What is clear is that GSK have a hell of a lot to offer. Expect that we are at a price that could make us vulnerable | hamid1970 | |
15/8/2022 21:08 | Berny3 - Thanks for posting, reading that document I would assume that Elliot are still involved. Expect the CEO position is the next change required. Someone who can execute against the vision and release the value. Not sure Emma can cut it and will be the next shoe to drop | hamid1970 | |
15/8/2022 21:02 | so what do they think now after the latest ex-pose i wonder? | lippy4 | |
15/8/2022 20:20 | This is worth reading. It is teh letter from Elliot advisors over why they took their £3bln stake in the company. | berny3 | |
15/8/2022 18:58 | Whats the forecast yield for gsk | coxsmn | |
15/8/2022 16:43 | strange this did not happen before splitting the company??? | lippy4 | |
15/8/2022 16:02 | Looks like litigation and short story running out of steam..... Next stop is a rise...... Unless there is more litigation news - dont hold your breath - it will be a long wait. | netcurtains | |
15/8/2022 15:55 | Don't be fooled into this Risky level. The worry will carry on and increase as trials in Illinois are due to begin on 22 August. Remember GSK can fall quickly as further bad news in the pipeline as claims against GSK increase. | halfpenny | |
15/8/2022 15:51 | Next stop 1600 | netcurtains | |
15/8/2022 15:40 | GSK still risky any bid would be at 800 so be patient and further falls will be dramatic once we get to legal cases starting end August. Claims are now ramping up at record pace with more Lawyers involved !!! | halfpenny | |
15/8/2022 15:14 | Good posts wallywoo,my sentiments exactly.Post xd date this could drop lower due to time of year and low volume trade volatility but after selling pre demerger i have profits from GSK to cushion any share price drops....within reason that is! | redbaron10 | |
15/8/2022 15:11 | Litigation uncertainty has been around since 2019. Not stopped the share price trotting back to 1800+. As I say, doubt very much it is a BP oil spill scenario. | wallywoo | |
15/8/2022 15:06 | Hmmm, I doubt any company would want to buy GSK given the litigation uncertainty (Bayer/Monsanto?!), unless of course it is another company listed as a defendant eg Pfizer or Sanofi! | spyder | |
15/8/2022 14:58 | Personally think this is the market targeting GSK for a bear raid. They are freshly demerged, so are vulnerable to more volatility. Being August also makes now a good time to hit the shares with many being away from their trading desk. There is always a law suit going on with these companies, just part of normal business. Zantac is not another BP oil spill scenario imo. Once that all settles down GSK will go back to being a nice defensive play in difficult times. It could of course, attract a bid at these prices too. So a share price recovery could happen very quickly. | wallywoo | |
15/8/2022 14:25 | It's all about TRUST - and the market doesn't for some reason | jonjoneil | |
15/8/2022 14:16 | Yes they have to put a PR stunt...let the market decide...or those in the know... | diku | |
15/8/2022 14:05 | Let's hope soTbh - I doubt whether the rns would have ever admitted there was a problem | watfordhornet | |
15/8/2022 13:56 | The recent RNS clearly states no case to answer. If so we (GSK and HLN) are at bargain prices. | pcok | |
15/8/2022 13:46 | My latest worry is that GSK will soon face multiple class action suits for violation of securities laws relating to this whole debacle. This is all pretty dreadful and I think anyone who bought Haleon post IPO but before this news broke would have pretty good reason to feel seriously aggrieved. The Board must be starting to feel a bit anxious. | spyder | |
15/8/2022 13:31 | Looks bang on the money sorry longs halfpenny15 Aug '22 - 10:51 - 30563 of 30572 | chesty1 | |
15/8/2022 13:29 | My biggest investment mistake (by a wide margin!) has been sticking with GSK over the last 35 years rather than AZN. Big mistake, huge … | spyder | |
15/8/2022 13:23 | xd this thurs. could see £13 after. | unastubbs | |
15/8/2022 12:26 | halfpenny 'You need a smart knowledgeable CEO/Captain to gain respect and trust' Totally agree with that statement, but good CEO's of pharmaceutical companies are as impossible to find as competent politicians | jonjoneil |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions